
Purinergic Signalling p. 61 - 74 (2017)
Update date:2022-07-30
Topics:
Dal Ben, Diego
Marchenkova, Anna
Thomas, Ajiroghene
Lambertucci, Catia
Spinaci, Andrea
Marucci, Gabriella
Nistri, Andrea
Volpini, Rosaria
Blocking membrane currents evoked by the activation of purinergic P2X3 receptors localized on nociceptive neurons represents a promising strategy for the development of agents useful for the treatment of chronic pain conditions. Among compounds endowed with such antagonistic action, 2′,3′-O-(2,4,6-trinitrophenyl)-ATP (TNP-ATP) is an ATP analogue, whose inhibitory activity on P2X receptors has been previously reported. Based on the results of molecular modelling studies performed with homology models of the P2X3 receptor, novel adenosine nucleotide analogues bearing cycloalkyl or arylalkyl substituents replacing the trinitrophenyl moiety of TNP-ATP were designed and synthesized. These new compounds were functionally evaluated on native P2X3 receptors from mouse trigeminal ganglion (TG) sensory neurons using patch clamp recordings under voltage clamp configuration. Our data show that some of these molecules are potent (nanomolar range) and reversible inhibitors of P2X3 receptors, without any apparent effect on trigeminal GABAA and 5-HT3 receptors, whose membrane currents were unaffected by the tested compounds.
Tai zhou world Pharm & Chem Co., Ltd
Contact:+86-576-85301198
Address:Rome 1001,wangjiang plaza,unti 2,jinshan east Road linhai,zhejiang,china
Contact:+86-570-4336358
Address:No.87 Building,Tianqian,Sidu Town
Contact:86-25-84683399
Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002
Wuhan Honor Bio-Pharm Co., Ltd
Contact:0086-027-88042901
Address:Suite 1420, No.9 Building, Wanda Plaza, No.209 Heping Avenue, Wuchang District, Wuhan City, Hubei Province, P.R.China
Shanghai ZaiQi Bio-Tech Co., Ltd.,
Contact:+86-21-5482 4098
Address:Bldg. No.7, No.201 MinYi Rd,Songjiang CaoHeJing High-Tech Park Shanghai 201516 P,R,China
Doi:10.1016/S0040-4020(01)83459-1
(1987)Doi:10.1071/CH08406
(2009)Doi:10.1016/j.bmcl.2009.03.145
(2009)Doi:10.1016/0008-6215(88)84147-8
(1988)Doi:10.1016/S0040-4020(01)86720-X
(1988)Doi:10.1007/BF01455479
(1988)